NICOLAS BARTHELEMY - 29 Oct 2021 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Director
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
29 Oct 2021
Net transactions value
-$309,374
Form type
4
Filing time
02 Nov 2021, 17:07:58 UTC
Previous filing
25 Jun 2021
Next filing
10 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $164,711 +1,285 +67% $128.18 3,192 29 Oct 2021 Direct
transaction RGEN Common Stock Sale $370,337 -1,285 -40% $288.20 1,907 29 Oct 2021 Direct F1
transaction RGEN Common Stock Sale $103,748 -360 -19% $288.19 1,547 29 Oct 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +1,285 $0.000000* 0 29 Oct 2021 Common Stock 1,285 $128.18 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 $288.20 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $288.20 to $288.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 This option is currently exercisable.